The Valley Desk

NCT00146770 · Interventional trial

Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients

Overall registry status Completed

Phase 3

Conditions Hurler's Syndrome, Hurler-Scheie Syndrome, Mucopolysaccharidosis I, Scheie Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov